Evusheld protects the vulnerable from Covid. Why are so few using it?
The drug was approved eight months ago as the best safeguard for immunocompromised patients. But the word does not seem to have spread far.
Source: statnews.com
Stay updated with breaking news from Ryan Roux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug was approved eight months ago as the best safeguard for immunocompromised patients. But the word does not seem to have spread far.